CHLOE BLAST

by Fairtility  · Based in Israel → — Advancing The Way to Better IVF Outcomes
Obstetrics & Gynecology

Contact vendor for details
Regulatory Status Disclosed

Overview

CHLOE BLAST is an AI-powered, cloud-based software as a medical device (SaMD) developed by Fairtility, a global leader in transparent AI solutions for reproductive medicine. This innovative tool is designed to provide adjunctive decision support for embryologists and clinicians during In Vitro Fertilization (IVF) procedures.

The system automatically analyzes time-lapse videos of developing embryos, typically retrieved from EmbryoScope Time-Lapse Incubators (TLI) systems. By leveraging convolutional neural networks (CNN), CHLOE BLAST assesses developmental events up to Day 3 to predict an embryo’s likelihood of progressing to the blastocyst stage by Day 5. This objective and data-driven approach aims to enhance the consistency and accuracy of embryo assessment, reducing the subjectivity inherent in traditional manual evaluations.

CHLOE BLAST integrates seamlessly into existing IVF workflows, providing a ‘CHLOE Score’ that aids in the selection of the most viable embryo(s) for transfer or freezing, particularly when multiple embryos are deemed suitable after morphological assessment. The platform is part of Fairtility’s broader CHLOE suite, which seeks to improve IVF outcomes, streamline laboratory efficiency, and foster greater transparency in the patient journey.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered embryo assessment and classification
  • Analysis of time-lapse embryo videos from TLI systems
  • Prediction of blastocyst development to Day 5
  • Provides adjunctive information for embryo selection on Day 3
  • Enhances objectivity and consistency in embryo evaluation
  • Integrates with IVF workflows and Time-Lapse Incubators (TLI)
  • Cloud-based Software as a Medical Device (SaMD)
  • Transparent AI for data-driven insights
  • Reduces subjective assessment variability among embryologists
  • Aids in clinical decision support for embryologists and clinicians

Use Cases

  • Optimizing embryo selection in In Vitro Fertilization (IVF)
  • Improving IVF success rates and live birth outcomes
  • Standardizing embryo assessment across fertility clinics
  • Enhancing workflow efficiency for embryologists
  • Facilitating transparent communication between clinicians and patients
  • Providing data-driven insights for fertility treatment planning

What Physicians Need to Know

IVF Support Tools
CHLOE Blast™ is an AI-powered decision support tool specifically designed for In Vitro Fertilization (IVF) labs. It assists embryologists and doctors in making more objective and consistent evaluations of embryos and oocytes. The platform aims to improve IVF outcomes by providing transparent, data-driven insights throughout the IVF journey. It has been shown to improve time to pregnancy by 20% or more, depending on the workflow.
Embryo Quality Assessment
CHLOE Blast™ is FDA-cleared and analyzes time-lapse embryo images to provide adjunctive information on embryo development, predicting progression to the blastocyst stage by Day 5. This information aids in selecting embryos for transfer on Day 3 when multiple embryos are suitable. The system uses a convolutional neural network (CNN) to analyze time-lapse imaging (TLI) videos from insemination to Day 3, generating a "CHLOE Score" which is a blastocyst development prediction value. It boasts a 96% accuracy in blastocyst prediction and 73% accuracy in implantation prediction. The AI algorithms can measure various embryo components automatically with higher accuracy and speed than embryologists.
Egg Quality Assessment
The CHLOE platform also includes CHLOE OQ, an AI-powered tool for assessing oocyte potential from a single image. This supports fertility preservation counseling and identifies oocyte quality issues that may impact IVF outcomes. CHLOE OQ is predictive of blastulation and has been validated with diverse datasets, showing that a higher OQ score correlates with a higher likelihood of an oocyte resulting in a blastocyst. This tool helps to replace subjective decision-making with personalized, data-driven analysis in egg freezing, egg donation, and IVF treatment.
Lab Performance Monitoring
CHLOE KPI™ is an AI-powered laboratory monitoring technology that tracks key parameters like fertilization and blastocyst formation rates. It provides live, automatic, and continuous monitoring of IVF clinic performance, helping to identify deviations from expected benchmarks and support quality control.
Treatment Insights & Patient Communication
CHLOE transforms complex lab data into clear visuals, enabling transparent and personalized patient conversations. It provides physicians with real-time progress visibility without manual lab updates and offers curated, visual summaries with key clinical insights like the IVF funnel and implantation probability. Patients can also receive a link to follow the development of their embryos, increasing transparency and engagement.
Physician Tip

Leverage CHLOE Blast™ for objective embryo selection, particularly when multiple embryos appear suitable for transfer, to enhance consistency and potentially improve time to pregnancy. Utilize the transparent AI insights to explain embryo development and implantation potential to patients, fostering trust and informed decision-making. Integrate CHLOE OQ for comprehensive oocyte assessment, especially in fertility preservation and egg donation, to provide evidence-based viability predictions. Regularly review CHLOE KPI™ data to proactively monitor lab performance, identify potential issues, and optimize workflows. The system's ability to automate data entry and provide remote access can free up valuable time for embryologists and clinicians to focus on patient care.

CHLOE Blast™ is a cloud-based software that integrates with Time-Lapse Incubator (TLI) systems, specifically the EmbryoScope version D incubator system, to automatically retrieve images. It offers a vendor-neutral approach for seamless integration with Electronic Medical Record (EMR) systems via APIs, aiming to eliminate manual data entry and mitigate human error. The system provides a web-based user interface accessible via Chrome browsers.

Details

Category OB/GYN AI, Radiology & Imaging AI
Pricing Contact vendor for details
DeploymentCloud-based Software as a Medical Device (SaMD), integrates with Time-Lapse Incubator (TLI) systems.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Obstetrics & Gynecology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-08-15K243851 510(k)CHLOE BLAST

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CHLOE BLAST

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for CHLOE BLAST.

View all on YouTube

Frequently Asked Questions

CHLOE Blast is an AI-powered embryo assessment tool that analyzes time-lapse embryo images to provide objective and consistent evaluations, aiding in the selection of embryos for transfer. It provides adjunctive information on embryo development to predict progression to the blastocyst stage by Day 5, which helps in selecting embryos for transfer on Day 3 when multiple embryos are suitable.
CHLOE Blast has received FDA 510(k) clearance, making it the first and only FDA-cleared machine learning AI-powered clinical decision support software for embryo assessment. Fairtility's solutions are also HIPAA and GDPR compliant, with AI processing performed on de-identified studies to protect patient privacy.
Yes, other AI-based embryo evaluation systems exist, such as iDAScore and KIDScore. Studies suggest that CHLOE scores correlate highly with live birth rates and may outperform systems like KIDScore in predicting pregnancy outcomes, offering more objective and standardized embryo quality assessment.
CHLOE Blast is intended to provide *adjunctive* information and should be used in conjunction with morphological assessment. It is currently designed for use only with images captured by the EmbryoScope version D incubator system.
CHLOE Blast is a cloud-based software that seamlessly integrates with existing time-lapse systems, automatically retrieving images and sending outputs via APIs to EMR systems. This vendor-neutral approach aims to create a fully digitized workflow, reduce manual entry, and enhance efficiency without adding redundancy.

Related Tools

ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
HERA W9 Diagnostic Ultrasound System
Samsung Medison CO.
OB/GYN AI
The HERA W9 Diagnostic Ultrasound System is a premium ultrasound system designed to elevate confidence and efficiency in women's healthcare. It combines superior imaging technology with an ergonomic design to advance workflow. Featuring the innovative Crystal Architecture™ and premier image processing technologies, HERA W9 produces realistic, high-resolution images for exceptional accuracy.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.
HERA Z30 Diagnostic Ultrasound System
Samsung Medison Co.
OB/GYN AI
The HERA Z30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system offering advanced imaging capabilities and AI-driven features for a wide range of clinical applications, with a focus on women's health.
R20 Diagnostic Ultrasound System
Samsung Medison Co.
OB/GYN AI
The Samsung R20 Diagnostic Ultrasound System is an AI-enabled general imaging ultrasound platform that delivers breakthrough imaging performance and AI-powered automation, setting a new standard in diagnostic precision and efficiency.
Voluson Expert 22, Voluson Expert 20, Voluson Expert 18
GE Medical Systems Ultrasound and Primary Care Diagnostics
OB/GYN AI
The Voluson Expert Series, including models 22, 20, and 18, are advanced ultrasound systems from GE HealthCare designed for women's health, offering high-resolution imaging, AI-powered automation, and an ergonomic design for efficient workflow and early detection in complex pregnancies.

See all OB/GYN AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-06 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.